Click here to get full coverage on Evaxion wraps skin cancer vaccine study, with 3-year data due in 2026 - Stock Titan

Evaxion wraps skin cancer vaccine study, with 3-year data due in 2026  Stock Titan

Evaxion wraps skin cancer vaccine study, with 3-year data due in 2026 - Stock Titan

Click here to get full coverage on Lake Street Maintains Evaxion A/S(EVAX.US) With Buy Rating, Maintains Target Price $9 - Moomoo

Lake Street Maintains Evaxion A/S(EVAX.US) With Buy Rating, Maintains Target Price $9  Moomoo

Lake Street Maintains Evaxion A/S(EVAX.US) With Buy Rating, Maintains Target Price $9 - Moomoo

Click here to get full coverage on Evaxion (EVAX) wraps EVX-01 phase 2 extension with 75% response - Stock Titan

Evaxion (EVAX) wraps EVX-01 phase 2 extension with 75% response  Stock Titan

Evaxion (EVAX) wraps EVX-01 phase 2 extension with 75% response - Stock Titan

Click here to get full coverage on Lake Street Raises Evaxion (EVAX) PT to $11 Following Positive Two-Year EVX-01 Melanoma Data - Yahoo Finance

Lake Street Raises Evaxion (EVAX) PT to $11 Following Positive Two-Year EVX-01 Melanoma Data  Yahoo Finance

Lake Street Raises Evaxion (EVAX) PT to $11 Following Positive Two-Year EVX-01 Melanoma Data - Yahoo Finance

Click here to get full coverage on Evaxion (NASDAQ: EVAX) director reports major share and warrant stakes - Stock Titan

Evaxion (NASDAQ: EVAX) director reports major share and warrant stakes  Stock Titan

Evaxion (NASDAQ: EVAX) director reports major share and warrant stakes - Stock Titan

Click here to get full coverage on Evaxion A/S (EVAX) director reports shares and warrant holdings - Stock Titan

Evaxion A/S (EVAX) director reports shares and warrant holdings  Stock Titan

Evaxion A/S (EVAX) director reports shares and warrant holdings - Stock Titan

Click here to get full coverage on Evaxion (EVAX) CSO Birgitte Rono details extensive warrant holdings - Stock Titan

Evaxion (EVAX) CSO Birgitte Rono details extensive warrant holdings  Stock Titan

Evaxion (EVAX) CSO Birgitte Rono details extensive warrant holdings - Stock Titan

Click here to get full coverage on Evaxion (NASDAQ: EVAX) to showcase AI-driven polio and CMV vaccines - Stock Titan

Evaxion (NASDAQ: EVAX) to showcase AI-driven polio and CMV vaccines  Stock Titan

Evaxion (NASDAQ: EVAX) to showcase AI-driven polio and CMV vaccines - Stock Titan

Click here to get full coverage on Evaxion shareholders meet in Denmark on April 16 for AGM - Stock Titan

Evaxion shareholders meet in Denmark on April 16 for AGM  Stock Titan

Evaxion shareholders meet in Denmark on April 16 for AGM - Stock Titan

Click here to get full coverage on Evaxion, Gates Foundation take AI polio vaccine designs to Congress - Stock Titan

Evaxion, Gates Foundation take AI polio vaccine designs to Congress  Stock Titan

Evaxion, Gates Foundation take AI polio vaccine designs to Congress - Stock Titan

Click here to get full coverage on Evaxion (EVAX) director Roberto Prego discloses shares and long-dated warrants - Stock Titan

Evaxion (EVAX) director Roberto Prego discloses shares and long-dated warrants  Stock Titan

Evaxion (EVAX) director Roberto Prego discloses shares and long-dated warrants - Stock Titan

Click here to get full coverage on Evaxion (EVAX) CFO Form 3/A details share and warrant stakes - Stock Titan

Evaxion (EVAX) CFO Form 3/A details share and warrant stakes  Stock Titan

Evaxion (EVAX) CFO Form 3/A details share and warrant stakes - Stock Titan

Click here to get full coverage on Evaxion A/S (EVAX) reports initial insider share and warrant holdings - Stock Titan

Evaxion A/S (EVAX) reports initial insider share and warrant holdings  Stock Titan

Evaxion A/S (EVAX) reports initial insider share and warrant holdings - Stock Titan

Click here to get full coverage on Evaxion A/S (NASDAQ: EVAX) convenes 2026 Annual General Meeting in Denmark - Stock Titan

Evaxion A/S (NASDAQ: EVAX) convenes 2026 Annual General Meeting in Denmark  Stock Titan

Evaxion A/S (NASDAQ: EVAX) convenes 2026 Annual General Meeting in Denmark - Stock Titan

Click here to get full coverage on Evaxion A/S (NASDAQ: EVAX) insider reports Form 3 share and warrant holdings - Stock Titan

Evaxion A/S (NASDAQ: EVAX) insider reports Form 3 share and warrant holdings  Stock Titan

Evaxion A/S (NASDAQ: EVAX) insider reports Form 3 share and warrant holdings - Stock Titan

Click here to get full coverage on AI vaccine firm Evaxion lands MSD deal worth up to $592 million - Stock Titan

AI vaccine firm Evaxion lands MSD deal worth up to $592 million  Stock Titan

AI vaccine firm Evaxion lands MSD deal worth up to $592 million - Stock Titan

Click here to get full coverage on Evaxion (NASDAQ: EVAX) director details indirect shares and multiple warrants - Stock Titan

Evaxion (NASDAQ: EVAX) director details indirect shares and multiple warrants  Stock Titan

Evaxion (NASDAQ: EVAX) director details indirect shares and multiple warrants - Stock Titan

Click here to get full coverage on [Form 3/A] Evaxion A/S Amended Initial Statement of Beneficial Ownership - Stock Titan

[Form 3/A] Evaxion A/S Amended Initial Statement of Beneficial Ownership  Stock Titan

[Form 3/A] Evaxion A/S Amended Initial Statement of Beneficial Ownership - Stock Titan

Click here to get full coverage on Evaxion A/S (EVAX) Form 3 outlines warrants and share holdings - Stock Titan

Evaxion A/S (EVAX) Form 3 outlines warrants and share holdings  Stock Titan

Evaxion A/S (EVAX) Form 3 outlines warrants and share holdings - Stock Titan

Click here to get full coverage on AI cancer vaccines for melanoma and deadly brain tumors on AACR stage - Stock Titan

AI cancer vaccines for melanoma and deadly brain tumors on AACR stage  Stock Titan

AI cancer vaccines for melanoma and deadly brain tumors on AACR stage - Stock Titan

Click here to get full coverage on Evaxion Completes One-Year Extension of Phase 2 Trial for AI-Designed Melanoma Vaccine EVX-01 - TipRanks

Evaxion Completes One-Year Extension of Phase 2 Trial for AI-Designed Melanoma Vaccine EVX-01  TipRanks

Evaxion Completes One-Year Extension of Phase 2 Trial for AI-Designed Melanoma Vaccine EVX-01 - TipRanks

Click here to get full coverage on EVAXION BIOTECH ($EVAX) Releases Q4 2025 Earnings - Quiver Quantitative

EVAXION BIOTECH ($EVAX) Releases Q4 2025 Earnings  Quiver Quantitative

EVAXION BIOTECH ($EVAX) Releases Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Evaxion (NASDAQ: EVAX) sets 2026 calendar: March, May, Aug., Nov. updates, AGM - Stock Titan

Evaxion (NASDAQ: EVAX) sets 2026 calendar: March, May, Aug., Nov. updates, AGM  Stock Titan

Evaxion (NASDAQ: EVAX) sets 2026 calendar: March, May, Aug., Nov. updates, AGM - Stock Titan

Click here to get full coverage on AI-driven vaccine firm Evaxion targets autoimmune diseases next globally - Stock Titan

AI-driven vaccine firm Evaxion targets autoimmune diseases next globally  Stock Titan

AI-driven vaccine firm Evaxion targets autoimmune diseases next globally - Stock Titan

Click here to get full coverage on AI vaccine firm Evaxion to detail 2025 finances and plans - Stock Titan

AI vaccine firm Evaxion to detail 2025 finances and plans  Stock Titan

AI vaccine firm Evaxion to detail 2025 finances and plans - Stock Titan

Click here to get full coverage on These 3 Penny Stocks are Soaring Today: PLUS, EVAX, DVLT - 24/7 Wall St.

These 3 Penny Stocks are Soaring Today: PLUS, EVAX, DVLT  24/7 Wall St.

These 3 Penny Stocks are Soaring Today: PLUS, EVAX, DVLT - 24/7 Wall St.

Click here to get full coverage on Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations - The Globe and Mail

Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations  The Globe and Mail

Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations - The Globe and Mail

Click here to get full coverage on Technical glitch pushes Evaxion’s 2025 annual report call to Friday - Stock Titan

Technical glitch pushes Evaxion’s 2025 annual report call to Friday  Stock Titan

Technical glitch pushes Evaxion’s 2025 annual report call to Friday - Stock Titan

Click here to get full coverage on $592M Potential Deal: Evaxion's AI-Powered Vaccine Platform Lands Major MSD Partnership for Novel Pathogen - Stock Titan

$592M Potential Deal: Evaxion's AI-Powered Vaccine Platform Lands Major MSD Partnership for Novel Pathogen  Stock Titan

$592M Potential Deal: Evaxion's AI-Powered Vaccine Platform Lands Major MSD Partnership for Novel Pathogen - Stock Titan

Click here to get full coverage on Merck in-licenses Evaxion vaccine candidate in a deal worth up to $600M - Seeking Alpha

Merck in-licenses Evaxion vaccine candidate in a deal worth up to $600M  Seeking Alpha

Merck in-licenses Evaxion vaccine candidate in a deal worth up to $600M - Seeking Alpha

Click here to get full coverage on Evaxion A/S 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:EVAX) 2026-03-06 - Seeking Alpha

Evaxion A/S 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:EVAX) 2026-03-06  Seeking Alpha

Evaxion A/S 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:EVAX) 2026-03-06 - Seeking Alpha

Click here to get full coverage on Cancer drug developer Evaxion Biotech's FY25 net loss narrows on higher revenue - TradingView

Cancer drug developer Evaxion Biotech's FY25 net loss narrows on higher revenue  TradingView

Cancer drug developer Evaxion Biotech's FY25 net loss narrows on higher revenue - TradingView

Click here to get full coverage on Insights into Evaxion Q4 Earnings - Benzinga

Insights into Evaxion Q4 Earnings  Benzinga

Insights into Evaxion Q4 Earnings - Benzinga

Click here to get full coverage on Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting - TipRanks

Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting  TipRanks

Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting - TipRanks

Click here to get full coverage on Evaxion Delays 2025 Annual Report Filing Due to Technical Issues - The Globe and Mail

Evaxion Delays 2025 Annual Report Filing Due to Technical Issues  The Globe and Mail

Evaxion Delays 2025 Annual Report Filing Due to Technical Issues - The Globe and Mail

Click here to get full coverage on Evaxion: Progress Unrecognized By Market And A Catalyst-Full 2025 (NASDAQ:EVAX) - Seeking Alpha

Evaxion: Progress Unrecognized By Market And A Catalyst-Full 2025 (NASDAQ:EVAX)  Seeking Alpha

Evaxion: Progress Unrecognized By Market And A Catalyst-Full 2025 (NASDAQ:EVAX) - Seeking Alpha

Click here to get full coverage on Evaxion A/S Q4 2025 Earnings Call Transcript - MarketBeat

Evaxion A/S Q4 2025 Earnings Call Transcript  MarketBeat

Evaxion A/S Q4 2025 Earnings Call Transcript - MarketBeat

Click here to get full coverage on Evaxion Readies Two-Year Cancer Vaccine Results For ESMO - RTTNews

Evaxion Readies Two-Year Cancer Vaccine Results For ESMO  RTTNews

Evaxion Readies Two-Year Cancer Vaccine Results For ESMO - RTTNews

Click here to get full coverage on Evaxion A/S expected to post a loss of 30 cents a share - Earnings Preview - TradingView

Evaxion A/S expected to post a loss of 30 cents a share - Earnings Preview  TradingView

Evaxion A/S expected to post a loss of 30 cents a share - Earnings Preview - TradingView

Click here to get full coverage on Maxim Group initiates Evaxion Biotech stock with buy on AI platform - Investing.com

Maxim Group initiates Evaxion Biotech stock with buy on AI platform  Investing.com

Maxim Group initiates Evaxion Biotech stock with buy on AI platform - Investing.com

Click here to get full coverage on EVAX SEC Filings - Evaxion AS 10-K, 10-Q, 8-K Forms - Stock Titan

EVAX SEC Filings - Evaxion AS 10-K, 10-Q, 8-K Forms  Stock Titan

EVAX SEC Filings - Evaxion AS 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened - Stocktwits

Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened  Stocktwits

Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened - Stocktwits

Click here to get full coverage on Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - TechStock²

Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough  TechStock²

Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - TechStock²

Click here to get full coverage on MSD declines option for Evaxion’s gonorrhea vaccine candidate - Investing.com

MSD declines option for Evaxion’s gonorrhea vaccine candidate  Investing.com

MSD declines option for Evaxion’s gonorrhea vaccine candidate - Investing.com

Click here to get full coverage on Evaxion A/S schedules annual general meeting for April 16, 2026 - Investing.com

Evaxion A/S schedules annual general meeting for April 16, 2026  Investing.com

Evaxion A/S schedules annual general meeting for April 16, 2026 - Investing.com

Click here to get full coverage on Earnings call transcript: Evaxion Biotech Q3 2025 sees stock rise 5.48% - Investing.com

Earnings call transcript: Evaxion Biotech Q3 2025 sees stock rise 5.48%  Investing.com

Earnings call transcript: Evaxion Biotech Q3 2025 sees stock rise 5.48% - Investing.com

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Evaxion Posts Transformational 2025, Extends Cash Runway Into 2027 on MSD Deal and Vaccine Progress - TipRanks

Evaxion Posts Transformational 2025, Extends Cash Runway Into 2027 on MSD Deal and Vaccine Progress  TipRanks

Evaxion Posts Transformational 2025, Extends Cash Runway Into 2027 on MSD Deal and Vaccine Progress - TipRanks

Click here to get full coverage on Evaxion A/S grants over 9 million warrants to board, management and employees - Investing.com

Evaxion A/S grants over 9 million warrants to board, management and employees  Investing.com

Evaxion A/S grants over 9 million warrants to board, management and employees - Investing.com

Click here to get full coverage on Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks

Evaxion Biotech Earnings Call Highlights AI and Runway  TipRanks

Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks

Click here to get full coverage on EVAX Stock Price, News & Analysis - Stock Titan

EVAX Stock Price, News & Analysis  Stock Titan

EVAX Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on Evaxion Stock Climbs Amid Biotech Surge - StocksToTrade

Evaxion Stock Climbs Amid Biotech Surge  StocksToTrade

Evaxion Stock Climbs Amid Biotech Surge - StocksToTrade

Click here to get full coverage on Notice to convene Evaxion’s Annual General Meeting - The Manila Times

Notice to convene Evaxion’s Annual General Meeting  The Manila Times

Notice to convene Evaxion’s Annual General Meeting - The Manila Times

Click here to get full coverage on Evaxion plans to file 2025 annual report later today - The Manila Times

Evaxion plans to file 2025 annual report later today  The Manila Times

Evaxion plans to file 2025 annual report later today - The Manila Times

Click here to get full coverage on Evaxion's Strategic Financial Moves Buy Critical Time: Here's What Changed - Stock Titan

Evaxion's Strategic Financial Moves Buy Critical Time: Here's What Changed  Stock Titan

Evaxion's Strategic Financial Moves Buy Critical Time: Here's What Changed - Stock Titan

Click here to get full coverage on Financial Turnaround: Evaxion Secures Future with $17M Raise, Dodges Delisting - Stock Titan

Financial Turnaround: Evaxion Secures Future with $17M Raise, Dodges Delisting  Stock Titan

Financial Turnaround: Evaxion Secures Future with $17M Raise, Dodges Delisting - Stock Titan

Click here to get full coverage on Evaxion announces business update and full year 2025 financial results - The Manila Times

Evaxion announces business update and full year 2025 financial results  The Manila Times

Evaxion announces business update and full year 2025 financial results - The Manila Times

Click here to get full coverage on Why Is Evaxion Biotech (EVAX) Stock Up 30% Today? - InvestorPlace

Why Is Evaxion Biotech (EVAX) Stock Up 30% Today?  InvestorPlace

Why Is Evaxion Biotech (EVAX) Stock Up 30% Today? - InvestorPlace

Click here to get full coverage on Evaxion A/S (EVAX) Stock Forecast and Price Target 2026 - MarketBeat

Evaxion A/S (EVAX) Stock Forecast and Price Target 2026  MarketBeat

Evaxion A/S (EVAX) Stock Forecast and Price Target 2026 - MarketBeat

Click here to get full coverage on EVAX Stock Price and Chart — NASDAQ:EVAX - TradingView

EVAX Stock Price and Chart — NASDAQ:EVAX  TradingView

EVAX Stock Price and Chart — NASDAQ:EVAX - TradingView

Click here to get full coverage on Evaxion Biotech Negotiates €3.5M Debt-to-Equity Deal with European Investment Bank to Boost Financial Position - Stock Titan

Evaxion Biotech Negotiates €3.5M Debt-to-Equity Deal with European Investment Bank to Boost Financial Position  Stock Titan

Evaxion Biotech Negotiates €3.5M Debt-to-Equity Deal with European Investment Bank to Boost Financial Position - Stock Titan

Click here to get full coverage on Evaxion Announces Business Update and Full Year 2023 Financial Results - Stock Titan

Evaxion Announces Business Update and Full Year 2023 Financial Results  Stock Titan

Evaxion Announces Business Update and Full Year 2023 Financial Results - Stock Titan

Click here to get full coverage on EVAX Forecast — Price Target — Prediction for 2027 - TradingView

EVAX Forecast — Price Target — Prediction for 2027  TradingView

EVAX Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Evaxion Biotech Delays ADS Ratio Change to January 2025, Plans 1:50 Share Adjustment - Stock Titan

Evaxion Biotech Delays ADS Ratio Change to January 2025, Plans 1:50 Share Adjustment  Stock Titan

Evaxion Biotech Delays ADS Ratio Change to January 2025, Plans 1:50 Share Adjustment - Stock Titan

Click here to get full coverage on Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration (NASDAQ:EVAX) - Seeking Alpha

Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration (NASDAQ:EVAX)  Seeking Alpha

Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration (NASDAQ:EVAX) - Seeking Alpha

Click here to get full coverage on Evaxion Biotech A/s Stock Price Forecast. Should You Buy EVAX? - StockInvest.us

Evaxion Biotech A/s Stock Price Forecast. Should You Buy EVAX?  StockInvest.us

Evaxion Biotech A/s Stock Price Forecast. Should You Buy EVAX? - StockInvest.us

Click here to get full coverage on Evaxion Biotech stock plunges to 52-week low of $1.7 amid steep annual decline - Investing.com

Evaxion Biotech stock plunges to 52-week low of $1.7 amid steep annual decline  Investing.com

EVAX

Price Chart

Key Statistics

Technicals

About EVAX

Latest News

Evaxion wraps skin cancer vaccine study, with 3-year data due in 2026 - Stock Titan

Lake Street Maintains Evaxion A/S(EVAX.US) With Buy Rating, Maintains Target Price $9 - Moomoo

Evaxion (EVAX) wraps EVX-01 phase 2 extension with 75% response - Stock Titan

Advanced Charts

Top Gainers

Top Losers